Ultima Genomics Patents – Insights & Stats (Updated 2023)

Ultima Genomics has a total of 232 patents globally, out of which 42 have been granted. Of these 232 patents, more than 83% patents are active. The United States of America is where Ultima Genomics has filed the maximum number of patents, followed by Europe(EPO) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ultima Genomics.

Ultima Genomics was founded in 2016. Ultima Genomics, Inc. operates as a biotechnology company. The company makes it easier for researchers to look at data for big populations in order to help unravel mysteries like why some people age more quickly than others, get cancer, or respond to treatment while others don’t.

Do read about some of the most popular patents of Ultima Genomics which have been covered by us in this article and also you can find Ultima Genomics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ultima Genomics patent portfolio.

How many patents does Ultima Genomics have?

Ultima Genomics has a total of 232 patents globally. These patents belong to 56 unique patent families. Out of 232 patents, 193 patents are active.

How Many Patents did Ultima Genomics File Every Year?

Ultima Genomics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 232 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantUltima Genomics Applications FiledUltima Genomics Patents Granted
20231115
20224217
2021476
2020871
2019253
201819
20171

How many Ultima Genomics patents are Alive/Dead?

Worldwide Patents

Ultima Genomics Patent Portfolio

How Many Patents did Ultima Genomics File in Different Countries?

Ultima Genomics Worldwide Patent Filing

Countries in which Ultima Genomics Filed Patents

CountryPatents
United States Of America68
Europe23
China21
Korea (South)12
Hong Kong (S.A.R.)11
Australia11
Canada10
Israel9
Japan6
Mexico2
Singapore2
Europe1

Where are Research Centers of Ultima Genomics Patents Located?

The research center of all the Ultima Genomics patents is The United States of America.

10 Best Ultima Genomics Patents

US10344328B2, WO2019099886A1 are the most popular patent in the Ultima Genomics portfolio. It has received 19 citations so far from companies.

Below is the list of 10 most cited patents of Ultima Genomics:

Publication NumberCitation Count
US10344328B219
WO2019099886A119
US10267790B114
WO2020186243A113
WO2019084158A113
US10512911B112
US20190271039A111
US10900078B210
US10852518B110
US20190153520A17

What Percentage of Ultima Genomics US Patent Applications Were Granted?

Ultima Genomics (Excluding its subsidiaries) has filed 46 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 22 have been granted leading to a grant rate of 95.65%.

Below are the key stats of Ultima Genomics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Ultima Genomics?

Law FirmTotal ApplicationsSuccess Rate
Ultima Genomics Inc Wsgr28100.0%
Wilson Sonsini Goodrich & Rosati12100.0%
Morrison & Foerster666.67%

What are Ultima Genomics key innovation segments?

What Technologies are Covered by Ultima Genomics?

The chart below distributes patents filed by Ultima Genomics in different countries on the basis of the technology protected in patents. It also represents the markets where Ultima Genomics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ultima Genomics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ultima Genomics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.